Xindian, Taiwan

Lih-Chyang Chen


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2011-2012

Loading Chart...
2 patents (USPTO):

Title: Lih-Chyang Chen: Innovator in Cancer Research

Introduction

Lih-Chyang Chen is a prominent inventor based in Xindian, Taiwan. He has made significant contributions to the field of cancer research through his innovative patents. With a total of 2 patents, Chen's work focuses on developing compounds that inhibit the expression of specific proteins involved in cancer cell survival.

Latest Patents

Chen's latest patents include a TP expression-inhibiting compound and a siRNA sequence thereof. This invention discloses a siRNA sequence that is partially or completely complementary to the sequence of TP, which is used to inhibit TP expression. This approach effectively reduces the survival rate of cancer cells in an anoxic environment. Another notable patent is the hnRNP K expression-inhibiting compound and siRNA sequence thereof. This invention also utilizes a siRNA sequence that is complementary to the sequence of hnRNP K to inhibit its expression, thereby reducing the survival rate of cancer cells in similar conditions.

Career Highlights

Lih-Chyang Chen is affiliated with Chang Gung University, where he conducts his research and development activities. His work has garnered attention for its potential impact on cancer treatment and therapy.

Collaborations

Chen collaborates with various researchers in his field, including his coworker Yu-Sun Chang. Their joint efforts contribute to advancing the understanding and treatment of cancer.

Conclusion

Lih-Chyang Chen's innovative work in cancer research highlights the importance of developing new therapeutic strategies. His patents reflect a commitment to improving cancer treatment outcomes through scientific innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…